Jiangsu HengRui Medicine Co., Ltd.: Hyperlipidemias trials

The registry lists 16 Hyperlipidemias studies with Jiangsu HengRui Medicine Co., Ltd. as lead sponsor. 3 are open to participants now and 0 have results posted.

Phase 1 9Phase 2 5Phase 3 3(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Extension Study to Evaluate the Safety and Efficacy of HRS-7249 in Patients With HypertriglyceridemiaRecruitingNCT07799688Phase 2
• A Trial to Evaluate the Efficacy and Safety of SHR-1918 in Patients With HyperlipidemiaRecruitingNCT07230730Phase 3
• A Phase II Study To Evaluate the Efficacy And Safety Of HRS-1301 In Participants With DyslipidemiaRecruitingNCT07229937Phase 2
• A Study to Assess the Effect of HRS-1301 on the Pharmacokinetics of Midazolam and Atorvastatin in Healthy ParticipantsCompletedNCT07608705Phase 1
• A Study of HRS-1301 Tablets in Healthy Subjects and Those With Impaired Kidney FunctionCompletedNCT07322016Phase 1
• A Clinical Study Evaluating the Efficacy and Safety of HRS-7249 in Treating Patients With HyperlipidemiaActive, not recruitingNCT07100418Phase 2
• A Clinical Trial of HRS-1301 on the Pharmacokinetics of Rosuvastatin Calcium Tablets in Healthy SubjectsCompletedNCT07097831Phase 1
• A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS-1301 in Healthy SubjectsCompletedNCT06857253Phase 1
• Study of SHR-1209 Administered by Single-site or Multiple-site Subcutaneous Injections in Healthy VolunteersCompletedNCT06837077Phase 1
• A Study on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS-7249 Injection in Healthy SubjectsCompletedNCT06541457Phase 1
• Efficacy and Safety of SHR-1918 in Patients With HyperlipidemiaCompletedNCT06471218Phase 2
• Safety and Tolerability of SHR-1918 in Healthy SubjectsActive, not recruitingNCT05432544Phase 1
• Study of Bioavailability, Pharmacodynamics and Safety of SHR-1209 Administered by Single Subcutaneous Injection at Different Sites in Healthy VolunteersCompletedNCT05370950Phase 1
• Efficacy and Safety of SHR-1209 Combined With Lipid-lowering Agents in Patients With HypercholesterolemiaCompletedNCT04885218Phase 3
• Study of SHR-1209 in the Treatment of Hypercholesterolemia and Hyperlipidemia Ⅲ StageCompletedNCT04849000Phase 3
• The Safety, Tolerability and Efficacy of Multiple Subcutaneous Injections of SHR-1209 in Subjects With HyperlipidemiaCompletedNCT03944109Phase 1/2